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Abstract 
  Rasakarpura, a Nirgandh type of Kupipakva Rasayana, used to cure skin disease. 
Rasakarpura was prepared as per the reference of Rasatarangini 6/65-71. It is prepared with 
Parada (mercury), Sandra Gandhakamla (concentrated sulphuric acid) and Saindhava Lavana 
(rock salt) in the ratio of 1: 1 ½ and approx 1 ½ . The clinical study was carried out on 80 
patients of Kshudra Kustha by using Rasakarpura Drava (0.1 % solution in distilled water) 
and same was compared with a standard drug i.e. Gandhaka Malahara. The obtained results 
of clinical trial suggest that both drugs have highly significant result on the cardinal 
symptoms of Kshudra Kustha. 
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Introduction: 
 Rasa Chikitsa is considered as the 
best among others due to their qualities. 
The drug formulations are to be found 
more potent and effective in terms of 
disease curing. There are so many drug 
formulations have been described by 
Rasacharyas and Rasakarpura is Nirgandh 
type of Parada compound which should be 
used more precautiously due to their 
minute dose and high efficacy along with 
some toxic effects like tastelessness, 
burning sensation in thorax, gingivitis, 
vomiting, melena, death etc in acute stage 
and abdominal pain, convulsion, fever, 
heamoptysis, gingivitis, death etc in 
chronic stage (1). The Kustha, a group of 
skin diseases are burning problem 
nowadays due to deforms in the normal 
structure of skin and patient become 
hateful in the society. Kshudra Kustha is 
diseases affecting the Twak and comprises 
with following symptoms described in 
Charak Samhita Chikitsasthan 7/21-26 
Kandu (itching), Srava (discharge), 
Vaivarnya (discoloration), Daha (burning), 
Matsyasaklopam (scaling), Pidika 
(papillae), Avadarana (cracking) (2). 
. It is described by all the Acharyas 
in their concerned classics. The disease 
often manifest on the external surface of 
the body. So Rasakarpura is prescribed in 
solution form as according to the reference 
of Rasa Tarangini 6/103 for local 
application by using cotton and apply 
genially along with the restricted salty and 
fermented diet.  
Rasakarpura is used as internal 
medicine in disease like Phiranga 
(syphilis), Atisara (diarrhea), Twak Vikara 
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(skin diseases) etc. (3).
 
It is also used as 
external drugs for local application in the 
form of Rasakarpura Drava (4) in different 
skin diseases and considered one of the 
best remedies for it.  
The ultimate object of drug 
research is to get solution which will be 
therapeutically effective and safe for all. In 
present study, Rasakarpura is used as 
Rasakarpura Drava and Gandhaka 
Malahara is used as known standard drug, 
both are subjected to patients of Kshudra 
Kushtha for evaluating therapeutic 
efficacy on Kshudra Kushtha Roga (skin 
disorder).  
The previous study of Rasakarpura 
on Vicharchika (eczema) as internal used 
reported significant result without any 
toxic or adverse effect (5). Amongst 
mercurial compounds it quite water 
soluble so it is absorbed through gut and 
skin (6) and produced effects. Though it is 
resembles to mercuric chloride (HgCl2) 
Rasakarpura is a mixture of Mercuric 
Chloride and other trace elements so it is 
found less toxic in therapeutic dose (7). 
 
Aims and objectives: 
 To evaluate the effect of Rasakarpura 
Drava and Gandhaka Malahara on 
general symptoms of Kshudra Kustha. 
 To observe the effect of Rasakarpura 
Drava and Gandhaka Malahara on 
haematological and bio chemical 
parameters. 
 
Materials and methods: 
Rasakarpura preparation method 
was firstly described under the heading of 
Shweta Parada Bhasma as “Ghansara 
Rasa” by Rasaprakash Sudhakara in 12th 
century AD(8).
 
Acharya Ananatadev Suri 
was the first man (9) who mentioned the 
Rasakarpura word which indicated its 
main content i.e. Rasa (mercury) and its 
physical property i.e. Karpura Varna 
(white colour).  
Rasakarpura is highly toxic drug 
and is enlisted in the list of poisonous 
substances under the Ayurvedic and Unani 
system of medicine in schedule E1 of 
drugs and cosmetic act 1940 (10). 
 For the preparation of Rasakarpura 
Drava one gram - 1 g of Rasakarpura was 
dissolved in one litre - 1 L of distilled 
water and filtrated through simple filter 
paper to make 0.1% dilution (11).
 
Siktha Taila was prepared by 1:5 
ratios of Siktha and Tila Taila (12). 20 part 
of Shuddha Gandhaka Churna was added 
at 70
0
C and mixed well for preparing the 
Gandhaka Malahara. 
 
Criteria for Selection of Patients:  
 The patient having classical symptom 
of Kshudra Kushtha like Kandu 
(itching), Srava (discharge), Vaivarnya 
(discoloration), Daha (burning), 
Matsyasaklopam (scaling), Pidika 
(papillae), Avadarana (cracking), were 
selected from O.P.D. and I.P.D. of 
I.P.G.T. & R.A., Hospital, Jamnagar.  
 Age group of patients is between 15 – 
75 years.  
 A special detailed proforma was 
prepared for comparing all the signs 
and symptoms based on both the 
Ayurvedic and Modern description and 
a detailed history of each patient was 
taken.  
 Laboratory investigations like TC, DC, 
ESR, blood sugar, blood urea, S. 
bilirubin etc. were carried out.  
 
Groups:  
Selected patients were randomly 
divided into two groups –  
 Group A: In this group, patients were 
treated with Rasakarpura Drava as an 
external application.  
 Group B: In this group, patients were 
treated with Gandhaka Malahara as an 
external application. 
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Posology:  
Dose:  Raskarpura Drava -  Q. 
S., bds. (min packing of 30 ml for a week 
or as per requirement) 
Gandhaka Malahara - Q. S., bds. 
(min packing of 50 g for a week or as per 
requirement) 
 
Duration:  Rasakarpura Drava 
 - 30 days  
  Gandhaka Malahara 
 - 30 days  
 
ADVICE: 
 Patients were advised to avoid 
Nidana, Viruddha Ahara like fish 
with milk, Yavaka, Udalaka, Dadhi 
and Vihara like Divaswapa, sinful 
acts etc (13), and also fermented 
foods etc., during the treatment 
schedule.  
 Patients were advised to keep the 
drug from the reach of children and 
apply it carefully to avoid its toxic 
effects. 
 
Criteria for Assessment   
Scoring Pattern 
Kandu (Itching) 
 No itching  0 
 Occasionally itching  + 1 
 Mild itching  + 2 
 Mild to moderate itching  + 3 
 Severe itching  + 4 
 
Vaivarnya (Discolouration)  
 Normal colour 0 
 Not normal but near to normal  +1 
 Reddish colouration +2 
 Slight black reddish discolouration +3 
 Deep black reddish discolouration +4 
 
Srava (Discharge)  
 No discharge  0 
 Occasionally discharge  +1 
 Discharge on itching +2  
 Mild to moderate discharge on 
itching 
+3 
 Severe discharge  +4 
 
Daha (Burning sensation)  
 No burning 0 
 Occasionally +1 
 Mild burning  +2 
 Mild to moderate burning  +3 
 Severe burning  +4 
 
Matsya Saklopam (Scaling)  
 No scaling  0 
 Mild scaling by rubbing or by 
itching 
+ 1 
 Moderate scaling by rubbing or 
by itching  
+ 2 
 Sever scaling by rubbing or by 
itching  
+ 3 
 Scaling without rubbing or itching + 4 
 
Shoola (Pain)  
 No pain 0 
 Occasionally pain  +1 
 Mild pain on touch +2 
 Mild to moderate pain  +3 
 Severe pain +4 
 
Pidika (Papillae)  
 No papillae  0 
 Starting of papillae +1 
 Moderately developed papillae  +2 
 Spreaded over extremities  +3 
 Severely spreaded all over body +4 
 
Avadarana (Crack)  
 No crack 0 
 Just superficial crack +1 
 Mild to moderate crack  +2 
 0.5 to 1.0 cm deep crack +3 
 Crack with bleedings  +4 
 
Criteria for Total Assessment Of 
Therapy: 
The result of the therapy were 
assessed after the completion on the basis 
of –  
 Improvement in selected symptoms 
and signs of diseases.  
 Investigations conducted before 
and after treatment. 
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The results of therapy have been 
categorized under four categories on the 
basis of improvement in symptoms.  
(1) Complete and markedly 
improvement: 75 – 100% relief in 
the signs and symptoms was 
considered as complete and 
markedly improvement.  
(2) Moderately improvement: >50% 
and <75% relief was considered as 
moderate improvement in signs 
and symptoms.  
(3) Mild improvement: 26 – 50% 
relief in the signs and symptoms 
was considered as mild 
improvement.  
(4) Unchanged: Below 25% relief was 
considered as unchanged.  
 
Follow Up: Patient was revived after 7 
days for a period of 30 days.  
 
Statistical Analysis: 
The obtained data were analyzed 
statistically. The values were expressed as 
mean  SEM. The data were analyzed by 
paired „t‟ test and comparison of both test 
drugs was analyzed by unpaired „t‟ test a 
level of P<0.05 and P<0.01 were 
considered as statistical significant and 
highly significant respectively. 
 
Observations and Results: 
For clinical trial total 80 patients 
were registered. 45 patients were 
registered in group A, out of which 30 
patients have completed the treatment 
course and 7 patients had complete relief 
in chief complaints within 30 days 
duration and 8 patients left against medical 
advice. In group B, total 35 patients were 
registered out of which 20 patients have 
completed the treatment course and 8 
patients had complete relief in chief 
complaints within 30 days duration and 7 
patients left against medical advice.  
From registered patients, 51.25% 
were female while remaining i.e. 48.75% 
patients were male. The maximum number 
i.e. 35.00% of patients each were of 15 – 
30 years and 31 – 45 years of age group, 
while 20% to 46 – 60 years and only 10% 
of the patients were belonged to 61 – 75 
years of age group. The data of Deha 
Prakriti depicts that maximum numbers of 
patients i.e. 38.75% were having Pitta-
kapha Prakriti, while 31.25% were of 
Kapha-vata Prakriti and 30.00% patents 
were having Vata-pitta Prakriti.  
The data pertaining to the effect of 
test drug and standard drug on cardinal 
symptoms have been presented in Table – 
1. Haematological parameters (Table – 2) 
and Biochemical parameters (Table – 3) 
obtained data show the effect of test group 
and standard group on ESR (mm) reveals 
that, statistically non-significant decrease 
was found in test group, but statistically 
significant decrease was observed in 
standard group. Other parameters remain 
statistically non significant. 
The data of the chief complaints in 
Table - 4 shows that majority of the 
patients i.e. 90.00% were suffering from 
Kandu (itching) followed by 74.00% had 
Vaivarnyata (discolouration), 46.00% had 
Daha (burning sensation), 30.00% had 
Matsyasaklopam (scaling), 28.00% had 
Shoola (pain) and 18.00% each in Pidika 
(papillae) and Avadarana (crack).  
Markedly improvement was found 
in the symptoms like Kandu (81.48%), 
Vaivarnya (26.09%), Srava (84.21%), 
Daha and Matsyasaklopam each (78.57%), 
Shoola (83.33%), Pidika (66.67%) and 
Avadarana (50.00%) in Rasakarpura Drava 
treated group (group A), while Kandu 
(83.33%), Vaivarnya (42.86%), Srava, 
(75.00%), Daha (77.78%), Shoola 
(87.50%), Pidika (100%) and Avadarana 
(28.57%) in Gandhaka Malahara treated 
group (group B). (Table – 5) 
Moderate improvement was found 
in the symptoms like Kandu (18.52%), 
Vaivarnya (73.91%), Srava, (15.79%), 
Daha (21.43%), Matsyasaklopam 
(21.43%), Shoola (16.67%), Pidika 
(16.67%) and Avadarana (50.00%) in 
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Rasakarpura Drava treated group (group 
A), while Kandu (16.67%), Vaivarnya 
(50.00%), Srava, (12.50%), Daha 
(11.11%), Shoola (100%) and Avadarana 
(71.43%) in Gandhaka Malahara treated 
group (group B). (Table – 5) 
However, mild improvement was 
observed in the symptoms Daha i.e. 
11.11% only in Gandhaka Malahara 
treated group (group B). No patient found 
in Rasakarpura Drava treated group (group 
A) under this criteria. (Table – 5) 
In Rasakarpura Drava treated 
group (group A), patients were found in 
Pidika (16.67%), while in Gandhaka 
Malahara treated group (group B) 
Vaivarnya (7.14%), Srava (12.50%) and 
Shoola (12.50%) were remained 
unchanged. (Table – 5) 
On considering the data of general 
symptoms, it can be said that statistically 
significant result (P<0.05) was obtained in 
Kandu, while significant result was also 
found in Srava (P<0.05), whereas 
statistically non-significant results (P>0.1) 
were found in Vaivarnya and Daha in 
Rasakarpura Drava treated group (group 
A) in comparison to Gandhaka Malahara 
treated group (group B). (Table – 6) 
 
Discussion: 
 The mercuric chloride is soluble in 
water while Mercurous Chloride is almost 
insoluble in water (14). The analytical 
study suggests that Rasakarpura prepared 
by Rasa Tarangini method is 97.98% 
soluble in distilled water (15) so it is 
confirmed that Rasakarpura prepared by 
Rasa Tarangini method is mercuric 
chloride along with Sodium, Magnesium, 
Calcium etc trace elements (16) and due to 
this solution was prepared in distilled 
water for clinical trial. 
The present study was planned to 
evaluate the efficacy of Rasakarpura Drava 
and Gandhaka Malahara on Kshudra 
Kustha. Clinical trial was carried out on 80 
patients having classical signs and 
symptoms of Kshudra Kustha. The 
patients were selected irrespective of their 
age, sex, religion etc. Selected patients 
were divided randomly into two groups i.e. 
group A and B treated with Rasakarpura 
Drava and Gandhaka Malahara 
respectively. The results were analyzed on 
the basis of improvement in classical 
features. Investigation parameters 
(hematological and biochemical) were also 
considered as supporting criteria for 
assessment.  
Total 45 patients were registered in 
group A, out of them 30 patients 
completed the treatment, 7 patients were 
relieved completely from the chief 
complaints within 28 days of treatment 
and so they did not want to continue the 
treatment, 8 patients left against medical 
advice. In group B, total 35 patients were 
registered out of them 20 patients 
completed the treatment, 8 patients 
completely relieved from the chief 
complaints within 28 days of treatment 
schedule and so did not want to complete 
the treatment, 7 patients left against 
medical advice. It can be said that 
Rasakarpura Drava and Gandhaka 
Malahara both drugs are very effective on 
the chief symptoms of disease. Complaints 
are quickly relieved by drugs.  
 
Discussion on General Observation: 
Sex:  
It was observed that 51.25% of 
patients were female and 48.75% were 
male. On the basis of data it can be said 
that the disease occur in both sex almost 
equally.  
Age:  
Maximum numbers of patients i.e. 
35% each were from the age groups of 15–
30 and 31–45 years. The results suggest 
that diseases are prevalent in younger age.  
Deha Prakriti:  
Maximum numbers of patients 
were having Pitta-kapha Prakriti, but the 
numbers of the patients in other groups are 
very nearer to it and Deha Prakriti also 
depends on the age which shows, this 
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disease have no relation to the Deha 
Prakriti of patients.  
Disease:  
Out of all Kshudra Kustha – Dadru, 
Ekakustha and Vicharchika are common. 
The occurrence may be due to climatic 
condition, because these types of diseases 
occur chiefly in humid area
 
and the place 
where this study was carried out is humid 
region. 
Effect of therapy in improvement on 
chief symptoms:  
Effect of Rasakarpura Drava 
(group A), in improvement on the chief 
symptoms of Kshudra Kustha was found 
to be statistically highly significant. At the 
level of P<0.001 were obtained in Kandu, 
Vaivarnya, Srava, Daha and 
Matsyasaklopam; Shoola and Pidika at 
level of P<0.05; and in Avadarana P>0.1 
improvement was observed. Effect of 
Gandhaka Malahara (group B), in 
improvement on the chief symptoms of 
Kshudra Kustha was also found to be 
statistically highly significant. At the level 
of P<0.001 were obtained in Kandu and 
Vaivarnya; while P<0.01 were obtained in 
Srava, Daha, Shoola and Avadarana, while 
in Matsyasaklopam and Pidika apparent 
improvement was observed. (Graph – 1) 
 
Effect of Therapy on hematological 
parameters:  
Analysis of the results shows that 
total 8 hematological parameters were 
studied. Out of these only ESR was found 
to be decreased statistically significant in 
Gandhaka Malahara treated group (group 
B). In Rasakarpura Drava applied group 
non-significant decrease was observed in 
WBC, lymphocyte, monocyte and ESR 
and statistically non-significant increase 
was found in PCV; while non-significant 
increase in WBC, neutrophil, hemoglobin, 
PCV and non-significant decrease in 
lymphocyte and eosinophil was observed 
in Gandhaka Malahara treated group. 
Erythrocyte Sedimentation Rate (ESR) 
was decreased significantly in Gandhaka 
Malahara treated group is suggestive of 
significant progress in the condition of 
chronic infection in the patients of this 
group.  
 
Effect of Therapy on biochemical 
parameters:  
Analysis of the results of obtained 
biochemical parameters shows that local 
application of Rasakarpura Drava and 
Gandhaka Malahara did not produce any 
significant alteration in any of the studied 
parameters.  
 
Comparative effect of test drug and 
standard drug on the improvement of 
symptoms of Kshudra Kustha  
The main aim of the present study 
was to evaluate the better therapeutic 
efficacy of Rasakarpura Drava and 
Gandhaka Malahara. So the comparative 
results of therapy on various symptoms are 
being presented here.  
Markedly improvement was 
observed in symptoms like Srava, Daha, 
Matsyasaklopam, Avadarana whereas 
moderately improvement in Kandu, 
Vaivarnya, Srava, Daha, Shoola, Pidika 
while no change in Pidika symptoms was 
found in Rasakarpura Drava treated group.  
Gandhaka Malhara treated group 
shows markedly improvement in 
symptoms like Kandu, Vaivarnya, Shoola 
and Pidika while moderately improvement 
in Matsya Saklopam and Avadarana, while 
mild improvement in Daha and no change 
was found in Vaivarnya, Srava and Shoola 
symptoms.  
Rasakarpura Drava shows better 
improvement in the cardinal symptoms of 
the patients of Kshudra Kustha in 
comparison to Gandhaka Malahara treated 
patients, when overall improvement in the 
cardinal symptoms is considered. The 
comparative improvement was found to be 
statistically significant in Kandu and Srava 
symptoms and non-significant in Daha, 
while in Vaivarnya both drugs were found 
to be equally effective.  
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Conclusion:  
Rasakarpura and Gandhaka 
Malahara both are found to be effective in 
the symptoms of Kshudra Kustha on local 
application, but effect of Rasakarpura 
Drava is observed better than that of 
standard drug i.e. Gandhaka Malahara.  
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Table – 1: Effect of test and standard drug in patients on cardinal symptoms of 
Kshudra Kustha 
 
 
Symptoms 
Group Dose 
Mean  SEM % 
change 
‘t’ P 
B.T. A.T.  Change 
Kandu A 
(n=30) 
Q.S. 2.400.20 0.270.08 2.13  
0.18 
88.75 11.83 <0.001** 
B 
(n=20) 
Q.S. 1.65 .21 0.200.12 1.45  
0.20 
87.88 07.15 <0.001** 
Vaivarnya A 
(n=30) 
Q.S. 1.670.19 0.570.09 1.10  
0.14 
65.87 7.86 <0.001** 
B 
(n=20) 
Q.S. 1.550.26 1.050.22 1.10  
0.22 
70.98 5.00 <0.001** 
Srava A 
(n=30) 
Q.S. 1.370.21  0.100.06 1.270.20 92.70 6.35 <0.001** 
B 
(n=20) 
Q.S. 0.800.25 0.200.16 0.600.21 75.00 2.86 <0.01** 
Daha A 
(n=30) 
Q.S. 0.830.17 0.100.06 0.77  
0.76 
92.77 4.81 <0.001** 
B 
(n=20) 
Q.S. 0.800.22 0.150.11 0.65  
0.18 
81.25 3.61 <0.01** 
Matsya 
Saklopam 
A 
(n=30) 
Q.S. 1.070.23 0.130.06 0.90  
0.20 
84.11 4.50 <0.001** 
B 
(n=20) 
Q.S. 0.100.10 0.050.05 0.05  
0.05 
50.00 1.00 >0.1 
Shoola A 
(n=30) 
Q.S. 0.370.15 0.030.03 0.33  
0.14 
89.18 2.36 <0.05* 
B 
(n=20) 
Q.S. 0.700.21 0.150.15 0.60  
0.20 
85.70 3.00 <0.01** 
Pidika A 
(n=30) 
Q.S. 0.330.14 0.070.05 0.27  
0.13 
81.82 2.08 <0.05* 
B 
(n=20) 
Q.S. 0.300.18 0.000.00 0.30  
0.18 
100 1.67 >0.1 
Avadarana A 
(n=30) 
Q.S. 0.130.09 0.030.03 0.10  
0.07 
76.92 1.43 >0.1 
B 
(n=20) 
Q.S. 1.000.33 0.350.13 0.65  
0.22 
35.00 2.95 <0.01** 
 
** = Highly significant  * = Significant  = Decrease 
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Table – 2: Effect of test and standard drug on Haematological parameters in patients of 
Kshudra Kustha 
 
 
Parameters 
Group Dose 
Mean  SEM % 
change 
‘t’ P 
B.T. A.T.  Change 
Neutrophil(%) A 
(n=30) 
Q.S. 
58.071.20 58.431.10 0.501.04 0.86 0.48 >0.1 
B 
(n=20) 
Q.S. 
58.201.21 59.951.77 1.751.75 3.01 1.0 >0.1 
Lymphocyte 
(%) 
A 
(n=30) 
Q.S. 
35.431.13 35.371.10 0.070.96 0.20 0.07 >0.1 
B 
(n=20) 
Q.S. 
35.201.17 34.001.74 1.201.73 3.41 0.69 >0.1 
Eosinophyl 
(%) 
A 
(n=30) 
Q.S. 3.37  0.22 3.27  0.14  0.110.24 3.26 0.46 >0.1 
B 
(n=20) 
Q.S. 3.60  0.18 3.15  0.15 0.450.22 12.50 2.05 >0.05 
Monocyte (%) A 
(n=30) 
Q.S. 3.13  0.09 2.93  0.11 0.200.12 6.39 1.66 >0.1 
B 
(n=20) 
Q.S. 3.00  0.10 2.90  0.10 0.100.14 3.33 0.71 >0.1 
Hemoglobin 
(g%) 
A 
(n=30) 
Q.S. 
12.280.27 12.430.30 0.110.21 0.90 0.52 >0.1 
B 
(n=20) 
Q.S. 
11.710.40 11.930.43 0.410.21 3.42 1.90 >0.05 
PCV (%) A 
(n=30) 
Q.S. 
38.120.74 38.720.83 0.600.54 1.57  1.11 >0.1 
B 
(n=20) 
Q.S. 
36.751.18 37.321.22 1.110.88 3.02 1.26 >0.1 
ESR (mm) A 
(n=30) 
Q.S. 
21.773.67 18.132.81 3.673.44 16.86 1.07 >0.1 
B 
(n=20) 
Q.S. 
31.204.74 22.703.42 8.503.61 27.24 2.35 <0.05* 
 
 = Decrease   = Increase  * = Significant 
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Table – 3: Effect of test and standard drug on Biochemical parameters in patients of 
Kshudra Kustha 
 
Parameters Group Dose 
Mean  SEM % 
change 
‘t’ P 
B.T. A.T.  Change 
Blood 
Sugar 
(mg/dl) 
A 
(n=30) 
Q.S. 
93.222.06 95.934.16 3.874.29 4.15 0.90 >0.1 
B 
(n=20) 
Q.S. 
90.652.54 91.452.67 0.803.28 0.88 0.24 >0.1 
S. 
creatinine 
(mg/dl) 
A 
(n=30) 
Q.S. 1.01  0.03 1.97  0.02 0.030.03 2.97 1.0 >0.01 
B 
(n=20) 
Q.S. 1.01  0.03 0.98  0.02 0.030.03 2.97 1.0 >0.1 
S. 
cholesterol 
(mg/dl) 
A 
(n=30) 
Q.S. 
185.004.43 179.835.16 4.003.63 2.16 1.10 >0.1 
B 
(n=20) 
Q.S. 
194.957.48 186.805.12 8.155.22 4.18 1.56 >0.1 
S. bilirubin 
(mg/dl) 
A 
(n=30) 
Q.S. 0.68  0.04  0.67  0.03  0.03 .03 4.41 0.75 >0.1 
B 
(n=20) 
Q.S. 0.66  0.04 0.61  0.05 0.050.03 7.57 1.67 >0.1 
SGPT 
(IU/L) 
A 
(n=30) 
Q.S. 
20.430.93 20.630.87 0.171.02 0.83 0.17 >0.1 
B 
(n=20) 
Q.S. 
24.603.23 20.301.57 4.152.23 16.87 1.86 >0.05 
SGOT 
(IU/L) 
A 
(n=30) 
Q.S. 
20.530.75 20.930.71 0.040.97 1.97 0.41 >0.1 
B 
(n=20) 
Q.S. 
21.251.92 21.551.09 0.301.65 1.41 0.18 >0.1 
Alkaline 
phosphatase 
(IU/L) 
A 
(n=30) 
Q.S. 
66.104.03 65.673.04 0.434.19 0.65 0.10 >0.1 
B 
(n=20) 
Q.S. 
66.453.54 60.353.76 6.104.46 9.18 1.37 >0.1 
S. albumin 
(g/dl) 
A 
(n=30) 
Q.S. 3.99  0.04 3.99  0.05 0.010.01 0.25 0.17 >0.1 
B 
(n=20) 
Q.S. 4.09  0.05 4.07  0.06 0.030.06 0.73 0.50 >0.1 
S. globuline 
(g/dl) 
A 
(n=30) 
Q.S. 3.18  0.05 3.10  0.03 0.090.05 2.83 1.80 >0.05 
B 
(n=20) 
Q.S. 3.22  0.06 3.18  0.05 0.040.07 1.24 1.57 >0.1 
A/G Ratio A 
(n=30) 
Q.S. 1.25  0.02 1.23  0.02 0.030.03 2.40 1.0 >0.1 
B 
(n=20) 
Q.S. 1.23  0.03 1.25  0.02 0.020.04 1.63 0.5 >0.1 
S. total 
protein 
(g/dl) 
A 
(n=30) 
Q.S. 7.15  0.07 7.08  0.06 0.060.18 0.84 0.75 >0.1 
B 
(n=20) 
Q.S. 7.32  0.08 7.28  0.08 0.040.08 0.55 0.50 >0.1 
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Blood Urea 
(mg/dl) 
A 
(n=30) 
Q.S. 
21.231.03 20.630.80 0.600.94 2.83 0.64 >0.1 
B 
(n=20) 
Q.S. 
20.651.35 20.551.30 0.101.05 0.48 0.09 >0.1 
 
 = Decrease    = Increase 
 
Table – 4: Chief complaints wise distribution of 50 patients of Kshudra Kustha  
Chief Complaints 
No. of Patients 
Total % 
Group A Group B 
Kandu (itching) 27 18 45 90.00 
Vaivarnya (discolouration) 23 14 37 74.00 
Srava (discharge) 19 08 27 54.00 
Daha (burning sensation) 14 09 23 46.00 
Matsya Saklopam (scaling)  14 01 15 30.00 
Shoola (pain) 06 08 14 28.00 
Pidika (Papillae) 06 03 09 18.00 
Avadarana (crack) 02 07 09 18.00 
 
 
Table – 5:  Comparative Effect of test and standard drugs on improvement of symptoms in 
50 patients of Kshudra Kustha  
Symptoms Group 
Improvement (%) 
100 – 75 74 – 50 49 – 25 <25 
Kandu  
A 81.48 18.52 00.00 00.00 
B 83.33 16.67 00.00 00.00 
Vaivarnya  
A 26.09 73.91 00.00 00.00 
B 42.86 50.00 00.00 07.14 
Srava 
A 84.21 15.79 00.00 00.00 
B 75.00 12.50 00.00 12.50 
Daha 
A 78.57 21.43 00.00 00.00 
B 77.78 11.11 11.11 00.00 
Matsya Saklopam 
A 78.57 21.43 00.00 00.00 
B 00.00 100 00.00 00.00 
Shoola  
A 83.33 16.67 00.00 00.00 
B 87.50 00.00 00.00 12.50 
Pidika  
A 66.67 16.67 00.00 16.67 
B 100 00.00 00.00 00.00 
Avadarana 
A 50.00 50.00 00.00 00.00 
B 28.57 71.43 00.00 00.00 
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Table – 6: Comparative effect of test and standard drugs on improvement in general 
symptoms in the patients of Kshudra Kustha 
Group ‘n’ Dose 
Improvement  
Mean  SEM 
‘t’ P 
Kandu 
A 30 Q.S. 2.13  0.18 2.53 <0.05* 
B 20 Q.S. 1.45  0.20 - - 
Vaivarnya 
A 30 Q.S. 1.10  0.14  0.00 >0.1 
B 20 Q.S.  1.10  0.22  - - 
Srava 
A 30 Q.S.  1.27  0.20   2.31 <0.05* 
B 20 Q.S. 0.60  0.21 - - 
Daha 
A 30 Q.S. 0.77  0.16  0.50 >0.1 
B 20 Q.S.  0.65  0.18  - - 
 
* = Significant ** = Highly significant   = Decrease   = Increase 
 
 
Graph - 1: Graph shows the effect of both drug in chief symptoms 
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